-
Feb 2004
HLA class II polymorphisms determine responses to bacterial superantigens.
J ImmunolLlewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, Cohen J, Altmann DM -
Jan 2004
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
DiabetesPalmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW -
Jan 2004
Regulating the immune system: the induction of regulatory T cells in the periphery.
Arthritis Res TherBuckner JH, Ziegler SF -
Dec 2003
Transcription factors in autoimmunity.
Curr Opin ImmunolRamsdell F, Ziegler SF -
Nov 2003
Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers.
Ann N Y Acad SciReijonen H, Kwok WW, Nepom GT -
Nov 2003
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.
J Clin InvestWalker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF -
Oct 2003
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.
J VirolIyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL, Hallahan CW, Davey RT Jr, Dybul M, Vogel S, Metcalf J, Connors M -
Sep 2003
HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.
J ImmunolDanke NA, Kwok WW -
Aug 2003
CD69-null mice protected from arthritis induced with anti-type II collagen antibodies.
Int ImmunolMurata K, Inami M, Hasegawa A, Kubo S, Kimura M, Yamashita M, Hosokawa H, Nagao T, Suzuki K, Hashimoto K, Shinkai H, Koseki H, Taniguchi M, Ziegler SF, Nakayama T -
Aug 2003
Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function.
J ImmunolKasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF -
Jul 2003
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.
Cancer ResChikamatsu K, Albers A, Stanson J, Kwok WW, Appella E, Whiteside TL, DeLeo AB -
May 2003
Low-avidity recognition by CD4+ T cells directed to self-antigens.
Eur J ImmunolGebe JA, Falk BA, Rock KA, Kochik SA, Heninger AK, Reijonen H, Kwok WW, Nepom GT -
May 2003
Conversations with GAD.
J AutoimmunNepom GT -
May 2003
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
DiabetesGreenbaum CJ, Harrison LC, Immunology of Diabetes Society. -
Mar 2003
Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.
MethodsReijonen H, Kwok WW